What is ABT's current stock price?

As of now, ABT is trading at $123.62, with a daily change of -0.84%.

What is ABT next earnings date?

ABT next earnings report is yet to be scheduled.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ABT Stock Analysis & IQ Rating | Abbott Laboratories

ABT

Abbott Laboratories

$123.62

-$1.05 | -0.84%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 141.23

MKT CAP

$ 214.96B

52W Low

$ 110.86

VOL

$ 6.82M

P/E Ratio

15.44

AVG VOL

$ 6.30M

RSI

30.38

TREND

Downtrend

ABT Stock IQ

Login to see Abbott Laboratories (ABT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABT Target Price

Login to display

Strengths

ABT Rewards

Upgraded on attractively valued

ABT Rewards

Earnings are forecast to grow

ABT Rewards

Outperform the market

ABT Rewards

Investors confidence is positive

Chart

$133.74 (-7.57%)

$134.28 (-7.94%)

$135.28 (-8.62%)

$115.03 (+7.47%)

1year

6month

3month

1month

ABT Risk Level

ABT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Low

LOW

HIGH

ABT Analysts Opinion

ABT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ABT Analysts Opinion

ABT Analysts opinion is positive and also has improved from the past 3 months

ABT Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

63%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

86%

44%

70%

ABT Street Opinion

ABT Street view is bullish and have positive views on the near-term outlook

ABT Performance Sentiment

Sentiments overview associated with ABT events and the stock performance.

63%

27%

Positive

Negative

33 out of 52
events present

14 out of 52
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$126.85

Resistance
Price

$126.34

Current Price Range

$134.59

Show methods +

ABT Earnings

The TTM reflects 12-month period, providing review of ABT financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

42,344

41,950

40,109

+2.75%

Cost of Revenue

18,711

18,706

17,975

+2.03%

Gross Profit

23,633

23,244

22,134

+3.33%

Operating Exp

16,501

16,419

15,656

+2.66%

Operating Inc

7,132

6,825

6,478

+4.93%

Net Interest Inc

-203

-215

-252

-

Interest Exp

549

559

637

-7.16%

Interest Inc

346

344

385

-5.20%

Other Inc Exp

426

403

438

-1.38%

EPS Growth

7.73

7.74

3.30

+53.05%

ABT Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

3.29

Linked to ABT

IQ

Close Price

Change

CVKD

4.00

13.67

+5.12%

PFE

3.82

24.65

+1.42%

MRK

4.03

85.98

-0.35%

OGN

3.26

6.75

+2.74%

NVS

3.86

123.79

+0.96%

ABT Latest Analysis +

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Fri Oct 31, 2025

$123.62 | -0.84%

Potential

Is the Market ish or Bearish on Abbott Laboratories?. ABT) short interest as a percent of float has risen 6.67% since its last report. According to exchange reported data there are now Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will fall. Traders make money from short selling if ...

Tue Oct 28, 2025

$126.61 | -0.45%

Potential

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Fri Oct 24, 2025

$126.85 | +0.42%

Potential

Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience.

Tue Oct 21, 2025

$127.54 | -1.51%

Rating

Abbott Q3 Earnings Review: Tariff Diagnostics Cap Near-Term Gains. Abbott posts strong Q3 growth across key segments but tariff pressures and weak Diagnostics weigh on near-term momentum.

Mon Oct 20, 2025

$129.51 | +0.75%

Potential

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Mon Oct 20, 2025

$129.51 | +0.75%

Potential

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Fri Oct 17, 2025

$128.54 | +0.71%

Potential

Abbott Labs stock price target raised to $158 from $154 at UBS.

Fri Oct 17, 2025

$128.54 | +0.71%

Potential

Evercore ISI Group Maintains Abbott Laboratories (ABT) Outperform Recommendation. Fintel reports that on October 16 2025 Evercore ISI Group maintained coverage of Abbott Laboratories (NYSE:ABT) with a Outperform recommendation. Analyst Price Forecast Suggests 13.29% Upside

Fri Oct 17, 2025

$128.54 | +0.71%

Rating

Raymond James Maintains Abbott Laboratories (ABT) Outperform Recommendation. Fintel reports that on October 16 2025 Raymond James maintained coverage of Abbott Laboratories (NYSE:ABT) with a Outperform recommendation. Analyst Price Forecast Suggests 13.29% Upside

Fri Oct 17, 2025

$128.54 | +0.71%

Potential

Rating

FAQ About ABT Stock Insights

What is ABT current stock price?

What are ABT stock strengths?

What risks are associated with ABT stock?

When is ABT next earnings report?

What is ABT market cap and volume?

What is ABT's current Stock IQ?

Should I buy ABT stock right now?

Is ABT a Strong Buy right now?

What does a 'Strong Buy' rating mean for ABT?

What does a 'Strong Sell' rating mean for ABT?

What factors influence ABT's Stock IQ?

Explore our ABT Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ABT Stock Strategies
Effective Risk Management

FIND US ON

Receive our ABT Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ABT

Abbott Laboratories

Current Price

$123.62

-$1.05 | -0.84%

52W High

$ 141.23

MKT CAP

$ 214.96B

52W Low

$ 110.86

VOL

$ 6.82M

P/E Ratio

15.44

AVG VOL

$ 6.30M

RSI

30.38

TREND

Downtrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ABT Rewards

Upgraded on attractively valued

ABT Rewards

Earnings are forecast to grow

ABT Rewards

Outperform the market

ABT Rewards

Investors confidence is positive

Linked to ABT

Symbol

IQ

Close

Change

CVKD

4.00

13.67

+5.12%

PFE

3.82

24.65

+1.42%

MRK

4.03

85.98

-0.35%

OGN

3.26

6.75

+2.74%

NVS

3.86

123.79

+0.96%

ABT Stock IQ

Login to unlock Abbott Laboratories (ABT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$133.74 (-7.57%)

$134.28 (-7.94%)

$135.28 (-8.62%)

$115.03 (+7.47%)

1year

6month

3month

1month

ABT Analysts Opinion

ABT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ABT Analysts Opinion

ABT Analysts opinion is positive and also has improved from the past 3 months

ABT Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

63%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

86%

44%

70%

ABT Street Opinion

ABT Street view is bullish and have positive views on the near-term outlook

ABT Risk Level

ABT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Low

LOW

HIGH

ABT Performance Sentiment

Sentiments overview associated with ABT events and the stock performance.

63%

27%

Positive

Negative

33 out of 52
events present

14 out of 52
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$126.85

Resistance
Price

$126.34

Current Price Range

$134.59

Show methods +

ABT Earnings

The TTM data reflects the most recent 12-month period, providing overview of ABT financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

42,344

41,950

40,109

+2.75%

Cost of Revenue

18,711

18,706

17,975

+2.03%

Gross Profit

23,633

23,244

22,134

+3.33%

Operating Exp

16,501

16,419

15,656

+2.66%

Operating Inc

7,132

6,825

6,478

+4.93%

Net Interest Inc

-203

-215

-252

-

Interest Exp

549

559

637

-7.16%

Interest Inc

346

344

385

-5.20%

Other Inc Exp

426

403

438

-1.38%

EPS Growth

7.73

7.74

3.30

+53.05%

ABT Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

3.29

ABT Latest Analysis

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Fri Oct 31, 2025

$123.62 | -0.84%

Potential

Is the Market ish or Bearish on Abbott Laboratories?. ABT) short interest as a percent of float has risen 6.67% since its last report. According to exchange reported data there are now Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will fall. Traders make money from short selling if ...

Tue Oct 28, 2025

$126.61 | -0.45%

Potential

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Fri Oct 24, 2025

$126.85 | +0.42%

Potential

Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience.

Tue Oct 21, 2025

$127.54 | -1.51%

Rating

Abbott Q3 Earnings Review: Tariff Diagnostics Cap Near-Term Gains. Abbott posts strong Q3 growth across key segments but tariff pressures and weak Diagnostics weigh on near-term momentum.

Mon Oct 20, 2025

$129.51 | +0.75%

Potential

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Mon Oct 20, 2025

$129.51 | +0.75%

Potential

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Fri Oct 17, 2025

$128.54 | +0.71%

Potential

Abbott Labs stock price target raised to $158 from $154 at UBS.

Fri Oct 17, 2025

$128.54 | +0.71%

Potential

Evercore ISI Group Maintains Abbott Laboratories (ABT) Outperform Recommendation. Fintel reports that on October 16 2025 Evercore ISI Group maintained coverage of Abbott Laboratories (NYSE:ABT) with a Outperform recommendation. Analyst Price Forecast Suggests 13.29% Upside

Fri Oct 17, 2025

$128.54 | +0.71%

Rating

Raymond James Maintains Abbott Laboratories (ABT) Outperform Recommendation. Fintel reports that on October 16 2025 Raymond James maintained coverage of Abbott Laboratories (NYSE:ABT) with a Outperform recommendation. Analyst Price Forecast Suggests 13.29% Upside

Fri Oct 17, 2025

$128.54 | +0.71%

Potential

Rating

Discover ABT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABT. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ABT Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABT Stock trends

ABT Stock performance

ABT Stock analysis

ABT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

ABT Stock Analysis & IQ Rating | Abbott Laboratories

ABT Stock IQ

ABT Target Price

ABT Risk Level

ABT Analysts Opinion

ABT Street Consensus

ABT Performance Sentiment

Technical Price Levels

ABT Financial Health

Explore our ABT Stock insights

Receive our ABT Daily Alerts

ABT Stock IQ

ABT Street Consensus

ABT Risk Level

Technical Price Levels

Discover ABT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABT. We're here to help you make informed investment decisions today.

Receive our ABT Daily Alerts

ABT Runner Alarm